Switch to:
More From Other Websites
1:08 pm BioTime's Asterias subsidiary concludes enrollment of its Phase 1/2a clinical trial... Aug 31 2015
BioTime Subsidiary Asterias Therapeutics Concludes Recruitment of Initial Safety Cohort of the... Aug 31 2015
BioTime Management to Present at Rodman & Renshaw 17th Annual Global Investment Conference Aug 28 2015
Asterias Biotherapeutics to Present at Upcoming Investor Conferences Aug 27 2015
BIOTIME INC Financials Aug 21 2015
BIOTIME INC Files SEC form 8-K, Unregistered Sale of Equity Securities Aug 20 2015
The Wistar Institute and BioTime Subsidiary OncoCyte Corporation Expand Agreement to Develop... Aug 18 2015
The Wistar Institute and BioTime Subsidiary OncoCyte Corporation Expand Agreement to Develop... Aug 18 2015
BIOTIME INC Files SEC form 8-K, Regulation FD Disclosure Aug 18 2015
Is Google's Switch To Alphabet Good For Healthcare? Definitely Maybe Aug 11 2015
BioTime, Inc. Reports Second Quarter 2015 Results and Recent Developments Aug 10 2015
BIOTIME INC Files SEC form 8-K, Results of Operations and Financial Condition Aug 10 2015
BioTime, Inc. Reports Second Quarter 2015 Results and Recent Developments Aug 10 2015
Asterias Biotherapeutics Reports Second Quarter Results Aug 10 2015
BioTime Announces the Issuance of 27 New Patents Protecting Stem Cell-Based Product Development Aug 10 2015
BioTime Announces the Issuance of 27 New Patents Protecting Stem Cell-Based Product Development Aug 10 2015
Asterias Biotherapeutics to Report Second Quarter Results on August 10, 2015 Jul 29 2015
OncoCyte Announces Appointment of Andy Arno to Board of Directors Jul 15 2015
OncoCyte Announces Appointment of Andy Arno to Board of Directors Jul 15 2015
BIOTIME INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jul 15 2015
BIOTIME INC Files SEC form 8-K, Other Events Jul 02 2015
William Annett Named Chief Executive Officer of OncoCyte Corporation Jun 16 2015
William Annett Named Chief Executive Officer of OncoCyte Corporation Jun 16 2015
BioTime to Present at the Jefferies 2015 Global Healthcare Conference May 20 2015
BioTime to Present at the Jefferies 2015 Global Healthcare Conference May 20 2015
OncoCyte’s Collaborators at The Wistar Institute Present Positive Clinical Interim Results of... May 19 2015
OncoCyte’s Collaborators at The Wistar Institute Present Positive Clinical Interim Results of... May 19 2015
BIOTIME INC Files SEC form 8-K, Regulation FD Disclosure May 19 2015
OncoCyte Corporation Completes Equity Financing Round May 14 2015
OncoCyte Corporation Completes Equity Financing Round May 14 2015
BIOTIME INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits May 14 2015
BioTime’s Subsidiary Cell Cure Neurosciences Ltd. Awarded $1.6 Million Grant From Israel’s... May 13 2015
BioTime’s Subsidiary Cell Cure Neurosciences Ltd. Awarded $1.6 Million Grant From Israel’s... May 13 2015
BIOTIME INC Files SEC form 8-K, Other Events May 13 2015
BioTime, Inc. Reports First Quarter 2015 Results and Recent Corporate Accomplishments May 11 2015
Cell Cure Neurosciences Announces Preclinical Efficacy Data Demonstrating OpRegen® Preserves Vision May 04 2015
BioTime’s Clinical Grade Stem Cells From Subsidiary ES Cell International to Be Used in Planned... Apr 27 2015
BioTime Licenses Beckman Research Institute of City of Hope to Manufacture Clinical Grade Stem Cells Apr 22 2015
BioTime Licenses Beckman Research Institute of City of Hope to Manufacture Clinical Grade Stem Cells Apr 22 2015
OncoCyte Announces Initial Data From Ongoing Clinical Study of Collagen Type X as a Marker and... Apr 20 2015
Positive Clinical Results of OncoCyte’s PanC-Dx™ Diagnostic Test Demonstrate High Level of... Apr 20 2015
OncoCyte Announces Availability of Abstracts With New Clinical Data From Studies of PanC-Dx™... Mar 26 2015
BioTime reports 4Q loss Mar 11 2015


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK